HEPA: Hepion Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling $10K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 26 | HEPA | Hepion Pharmaceuticals, Inc. | Fisher Danina | Director | 2026-09-29 | $10K | new |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-21 | 13G stake raised | Kenneth Rickel | 7.20% | +1.50 pts | SEC |
| 2026-09-16 | 13D amendment | KI Holdings Ltd. | 10.20% | SEC | |
| 2026-09-15 | New 13G stake | Kenneth Rickel | 5.70% | SEC | |
| 2026-08-20 | New 13D stake | Sireesh Appajosyula | 5.70% | SEC | |
| 2026-08-20 | 13D amendment | Gravitas Capital LP | 26.20% | SEC | |
| 2026-08-20 | New 13D stake | Gary Stetz | 5.70% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.